Completed PHASE2/PHASE3 INTERVENTIONAL 4-arm NCT00913120

Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery

Phase II/III Study of YM150 - A Placebo-controlled, Double-blind, Group Comparison Study in Patients Undergoing Elective Total Hip Replacement Surgery

Sponsor: Astellas Pharma Inc

Conditions Venous Thromboembolism

Interventions Enoxaparin Placebo YM150

Updated 7 times since 2017 Last updated: Jun 8, 2010 Started: May 31, 2009 Primary completion: Mar 31, 2010 Completion: Mar 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Venous Thromboembolism, this trial is completed. The trial is conducted by Astellas Pharma Inc and has accumulated 7 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2/PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2_PHASE3

First recorded

May 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Astellas Pharma Inc

Data source: Astellas Pharma Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bangkok, Thailand , Changhua, Taiwan , Chiang Mai, Thailand , Chiayi City, Taiwan , Chugoku, Japan , Chūbu, Japan , Daegu, South Korea , Hokkaido, Japan , Jeonnam, South Korea , Kansai, Japan and 6 more locations